Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Tower Corp (AMT) vs Tilray Brands Inc (TLRY) Price & Performance

American Tower Corp
Tilray Brands Inc

Price performance

Price movement over the last 24 hours

Key statistics

American Tower Corp vs Tilray Brands Inc — how do they compare? American Tower Corp trades at $169 (market cap $78.54B), while Tilray Brands Inc trades at $4.5 (market cap $544.44M). The key difference: American Tower Corp is far larger — about 144.3× Tilray Brands Inc's market cap, and American Tower Corp pays a 4.14% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

AMTTLRY
Market Cap
$78.54B$544.44M
Sector
Real EstateHealth
52-Week High
$232.35$21.00
52-Week Low
$162.11$4.31
Enterprise Value
$122.07B$641.59M
Dividend Yield
4.14%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Tower Corp

American Tower (AMT) trades at $168.59, up 2.18% today, with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals including a 26.81% net margin and 82.19% ROE. Recent news highlights its data center growth and sustainability initiatives, while analyst consensus remains strongly bullish with a $214.10 price target.

AMT presents a compelling long-term investment opportunity given its high profitability, dividend yield, and market leadership, though elevated debt levels and near-term technical weakness pose risks. Upside potential exists if the company continues executing on 5G and data center expansion, but investors should monitor interest rate sensitivity and competitive pressures.

Tilray Brands Inc

TLRY trades at $4.42, up 0.68% on the day, with a bearish technical outlook and mixed fundamentals. The stock shows low valuation ratios (P/S 0.55, P/B 0.35) but deep losses (net margin -156.67%) and negative cash flow from operations. Recent news highlights expansion in medical cannabis and new product launches, yet earnings misses and high debt-to-asset ratios signal ongoing challenges.

Outlook remains uncertain with profitability elusive; growth via acquisitions adds scale but not earnings. Analyst consensus is cautious (25% buy, 65% hold), reflecting skepticism about near-term turnaround. Key risks include sustained cash burn, competitive pressures, and regulatory hurdles in the cannabis sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Tower Corp

American Tower owns and operates more than 220,000 cell towers throughout the U.S., Asia, Latin America, Europe, and Africa. It also owns and/or operates 25 data centers in eight U.S. markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. The company operates more than 40,000 towers in the U.S., which accounted for more than half of its total revenue in 2021. Outside the U.S., American Tower's greatest presence is in India and Brazil, where it operates roughly 75,000 and 19,000 towers, respectively. American Tower operates as a real estate investment trust.

Read more on AMT

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY